These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34835109)

  • 41. Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk.
    Irvin SC; Herold BC
    PLoS One; 2015; 10(3):e0121135. PubMed ID: 25798593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
    Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
    J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to HIV-1 in humanized mice.
    Wessels JM; Lajoie J; Cooper MIJH; Omollo K; Felker AM; Vitali D; Dupont HA; Nguyen PV; Mueller K; Vahedi F; Kimani J; Oyugi J; Cheruiyot J; Mungai JN; Deshiere A; Tremblay MJ; Mazzulli T; Stearns JC; Ashkar AA; Fowke KR; Surette MG; Kaushic C
    Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31537512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice.
    Quispe Calla NE; Vicetti Miguel RD; Glick ME; Kwiek JJ; Gabriel JM; Cherpes TL
    J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29334191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
    Virutamasen P; Wangsuphachart S; Reinprayoon D; Kriengsinyot R; Leepipatpaiboon S; Gua C
    Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):269-74. PubMed ID: 7811192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health Care Provider Attitudes and Practices Related to 'Quick Start' Provision of Combined Hormonal Contraception and Depot Medroxyprogesterone Acetate to Adolescents.
    Morgan IA; Ermias Y; Zapata LB; Curtis KM; Whiteman MK
    J Adolesc Health; 2019 Feb; 64(2):211-218. PubMed ID: 30392865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells.
    Pridjian G; Schmit V; Schreiber J
    J Steroid Biochem; 1987 Mar; 26(3):313-9. PubMed ID: 2953940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.
    Cover J; Ba M; Drake JK; NDiaye MD
    Contraception; 2019 Feb; 99(2):137-141. PubMed ID: 30439358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
    Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM;
    AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progestin-only contraception: injectables and implants.
    Jacobstein R; Polis CB
    Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):795-806. PubMed ID: 24996766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood.
    Li L; Zhou J; Wang W; Huang L; Tu J; Baiamonte L; Stark M; Mills M; Hope TJ; Drobnis EZ; Quayle AJ; Schust DJ
    Reprod Biol Endocrinol; 2019 Feb; 17(1):26. PubMed ID: 30795774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
    Rahimy MH; Cromie MA; Hopkins NK; Tong DM
    Contraception; 1999 Oct; 60(4):201-8. PubMed ID: 10640166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with provision of depot medroxyprogesterone acetate to adolescents by US health care providers.
    Ermias Y; Morgan IA; Curtis KM; Whiteman MK; Horton LG; Zapata LB
    Contraception; 2019 May; 99(5):300-305. PubMed ID: 30763582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.
    Weinberg A; Park JG; Bosch R; Cho A; Livingston E; Aweeka F; Cramer Y; Watts DH; Luque AE; Cohn SE
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):137-45. PubMed ID: 26413850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
    Shulman LP; Oleen-Burkey M; Willke RJ
    Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
    Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CCR5 Expression Levels in HIV-Uninfected Women Receiving Hormonal Contraception.
    Sciaranghella G; Wang C; Hu H; Anastos K; Merhi Z; Nowicki M; Stanczyk FZ; Greenblatt RM; Cohen M; Golub ET; Watts DH; Alter G; Young MA; Tsibris AM
    J Infect Dis; 2015 Nov; 212(9):1397-401. PubMed ID: 25895986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
    Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
    Mishell DR
    J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
    Katz M; Newmark RL; Aronstam A; O'Grady N; Strome S; Rafie S; Karlin J
    Contraception; 2020 Dec; 102(6):392-395. PubMed ID: 32931811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.